A Medical Affairs consultant at a small / medium biotech company and former OB/GYN(practiced 19 years) has expertise across precision medicine, including hereditary cancers,oncology, the direct-to-consumer space, and endometriosis. Key challenges in the women’shealth space are considered insufficient investment, lacking prognostic tests, no gold standardsfor testing and treatment, regulatory / reimbursement barriers, and limited access to care. Theyconsider investment from the private sector to be more of a challenge compared to publicfunding. They believe unmet needs are highest in endometriosis, PCOS, pregnancycomplications, menstrual health, and menopause, and believe precision medicine activity will behighest in endometriosis and fertility. This stakeholder is excited by activity from 3Daughtersand Luna Genetics, but notes that the recent political climate post-Roe has created challengesfor NIPT. They believe the increasing number of female founders and CEOs will be a driver forinvestment and movement in the next 1-2 years.
PDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Individual call transcript of a single stakeholder discussing their views. This option is ideal for those who are interested in a specific stakeholder's perspective and insights on the topic.